Rankings
▼
Calendar
ALT Q1 2025 Earnings — Altimmune, Inc. Revenue & Financial Results | Market Cap Arena
ALT
Altimmune, Inc.
$353M
Q1 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$5,000
+0.0% YoY
Gross Profit
$5,000
100.0% margin
Operating Income
-$22M
-436300.0% margin
Net Income
-$20M
-391500.0% margin
EPS (Diluted)
$-0.26
QoQ Revenue Growth
+0.0%
Cash Flow
Operating Cash Flow
-$17M
Free Cash Flow
-$17M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$157M
Total Liabilities
$15M
Stockholders' Equity
$142M
Cash & Equivalents
$49M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$5,000
$5,000
+0.0%
Gross Profit
$5,000
-$102,000
+104.9%
Operating Income
-$22M
-$27M
+18.6%
Net Income
-$20M
-$24M
+19.8%
← FY 2025
All Quarters
Q2 2025 →